2nd Quarter - Report

LYMPHOMA RESEARCH FOUNDATION for LYMPHOMA RESEARCH FOUNDATION

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

PACT Act (H.R. 2846) and Senate Finance Committee request for feedback on chronic care management in the Medicare Program.

LobbyistCovered position, as disclosed
ELIZABETH GOSS —
ROBIN R LEVY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2846 (114th)

Medical/Disease Research/Clinical Labs MED

Congressionally Directed Medical Research Program

LobbyistCovered position, as disclosed
ROBIN R LEVY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Cancer Drug Parity Act of 2015 (H.R. 2739/ S. 1566)

LobbyistCovered position, as disclosed
ROBIN R LEVY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1566 (114th), H.R. 2739 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.